DENTSPLY SIRONA (NASDAQ:XRAY) Stock Price Down 4.3% - Should You Sell?

Key Points

• DENTSPLY SIRONA's stock price fell by 4.3% on Monday, reaching a low of $12.61 and experiencing a significant decrease in trading volume.
• Wall Street analysts have mixed ratings on the stock, with two analysts recommending a Buy rating, while the consensus holds a Hold rating and a price target of $18.64.
• The company announced a quarterly dividend of $0.16 per share, resulting in a 5.1% dividend yield, with shares trading ex-dividend on September 26th.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Get Free Report)'s stock price was down 4.3% on Monday . The company traded as low as $12.61 and last traded at $12.62. Approximately 502,819 shares were traded during trading, a decline of 83% from the average daily volume of 2,993,097 shares. The stock had previously closed at $13.19.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on XRAY. Wall Street Zen upgraded DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research report on Friday, September 26th. Stifel Nicolaus lowered their target price on DENTSPLY SIRONA from $19.00 to $17.00 and set a "hold" rating for the company in a report on Friday, August 8th. Barrington Research dropped their target price on DENTSPLY SIRONA from $21.00 to $18.00 and set an "outperform" rating for the company in a research report on Friday, August 8th. Weiss Ratings reissued a "sell (d-)" rating on shares of DENTSPLY SIRONA in a research report on Saturday, September 27th. Finally, UBS Group dropped their price objective on shares of DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating for the company in a report on Friday, August 8th. Two equities research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $18.64.

DENTSPLY SIRONA Stock Down 5.1%

The firm has a market cap of $2.50 billion, a price-to-earnings ratio of -2.64, a P/E/G ratio of 0.82 and a beta of 0.96. The firm's 50 day moving average price is $13.80 and its two-hundred day moving average price is $14.71. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.69 and a quick ratio of 1.11.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share for the quarter, topping analysts' consensus estimates of $0.50 by $0.02. The company had revenue of $936.00 million during the quarter, compared to analysts' expectations of $929.67 million. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The firm's revenue for the quarter was down 4.9% on a year-over-year basis. During the same period last year, the firm earned $0.49 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. As a group, sell-side analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 10th. Shareholders of record on Friday, September 26th will be given a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 5.1%. The ex-dividend date is Friday, September 26th. DENTSPLY SIRONA's payout ratio is presently -13.50%.

Institutional Trading of DENTSPLY SIRONA

A number of institutional investors have recently added to or reduced their stakes in XRAY. AQR Capital Management LLC lifted its position in shares of DENTSPLY SIRONA by 109.8% during the 2nd quarter. AQR Capital Management LLC now owns 13,316,771 shares of the medical instruments supplier's stock valued at $211,470,000 after acquiring an additional 6,970,086 shares during the period. Norges Bank acquired a new position in DENTSPLY SIRONA during the second quarter worth $39,700,000. Goldman Sachs Group Inc. boosted its position in DENTSPLY SIRONA by 827.3% during the first quarter. Goldman Sachs Group Inc. now owns 2,434,925 shares of the medical instruments supplier's stock worth $36,378,000 after purchasing an additional 2,172,343 shares in the last quarter. Price T Rowe Associates Inc. MD grew its holdings in DENTSPLY SIRONA by 11.3% in the first quarter. Price T Rowe Associates Inc. MD now owns 13,961,759 shares of the medical instruments supplier's stock valued at $208,590,000 after purchasing an additional 1,412,517 shares during the last quarter. Finally, Ninety One UK Ltd acquired a new stake in DENTSPLY SIRONA during the second quarter worth approximately $18,418,000. Hedge funds and other institutional investors own 95.70% of the company's stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.